Next Article in Journal
HIV-1 Protease: Structural Perspectives on Drug Resistance
Next Article in Special Issue
H5N1 Virus Evolution in Europe—An Updated Overview
Previous Article in Journal
HCV Innate Immune Responses
Previous Article in Special Issue
A Closer Look at the NS1 of Influenza Virus
Viruses 2009, 1(3), 1089-1109; doi:10.3390/v1031089

Pandemic Influenza Vaccines – The Challenges

1,* , 2
1 Myrdalskogen 95, N-5117 Ulset, Norway 2 Influenza Centre, The Gade Institute, University of Bergen, Laboratory Building, 5th Floor, Haukeland University Hospital, N-5021 Bergen, Norway
* Author to whom correspondence should be addressed.
Received: 14 August 2009 / Revised: 26 November 2009 / Accepted: 1 December 2009 / Published: 3 December 2009
(This article belongs to the Special Issue Influenza: Pandemics and Vaccinations)
View Full-Text   |   Download PDF [161 KB, uploaded 12 May 2015]


Recent years’ enzootic spread of highly pathogenic H5N1 virus among poultry and the many lethal zoonoses in its wake has stimulated basic and applied pandemic vaccine research. The quest for an efficacious, affordable and timely accessible pandemic vaccine has been high on the agenda. When a variant H1N1 strain of swine origin emerged as a pandemic virus, it surprised many, as this subtype is well-known to man as a seasonal virus. This review will cover some difficult vaccine questions, such as the immunological challenges, the new production platforms, and the limited supply and global equity issues.
Keywords: influenza; H5N1; H1N1; pandemic; vaccine; haemagglutinin (HA); neuraminidase (NA) influenza; H5N1; H1N1; pandemic; vaccine; haemagglutinin (HA); neuraminidase (NA)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Haaheim, L.R.; Madhun, A.S.; Cox, R. Pandemic Influenza Vaccines – The Challenges. Viruses 2009, 1, 1089-1109.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert